Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-22-001636
Filing Date
2022-01-12
Accepted
2022-01-11 21:46:12
Documents
5
Period of Report
2022-01-12

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea153882-6k_immuronlimit.htm 6-K 21468
2 IMMURON AWARDED A$6.2 MILLION US DOD FUNDING FOR TRAVELAN ea153882ex99-1_immuronlimit.htm EX-99.1 24614
3 GRAPHIC image_001.jpg GRAPHIC 1003
4 GRAPHIC ex99-1_001.jpg GRAPHIC 19105
5 GRAPHIC ex99-1_002.jpg GRAPHIC 4535
  Complete submission text file 0001213900-22-001636.txt   81461
Mailing Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053
Business Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053 61 03 9824 5254
Immuron Ltd (Filer) CIK: 0001660046 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-38104 | Film No.: 22525401
SIC: 2834 Pharmaceutical Preparations